Exchange Traded Concepts LLC grew its holdings in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 27.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 629,329 shares of the company's stock after purchasing an additional 136,212 shares during the quarter. Exchange Traded Concepts LLC owned about 0.23% of Core Scientific worth $8,842,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in CORZ. Sunbelt Securities Inc. acquired a new position in Core Scientific during the 2nd quarter worth about $33,000. Rise Advisors LLC raised its stake in shares of Core Scientific by 14.3% in the third quarter. Rise Advisors LLC now owns 8,000 shares of the company's stock worth $95,000 after acquiring an additional 1,000 shares during the last quarter. Xponance Inc. acquired a new position in shares of Core Scientific during the second quarter worth approximately $104,000. Amalgamated Bank bought a new stake in shares of Core Scientific during the second quarter valued at approximately $115,000. Finally, Arkadios Wealth Advisors acquired a new stake in shares of Core Scientific in the third quarter valued at approximately $119,000.
Core Scientific Stock Performance
CORZ stock traded down $0.36 during midday trading on Friday, hitting $15.98. 7,341,216 shares of the company's stock were exchanged, compared to its average volume of 6,601,615. Core Scientific, Inc. has a one year low of $2.61 and a one year high of $18.63. The company has a market cap of $4.46 billion and a PE ratio of -2.95. The stock's fifty day moving average price is $15.56 and its 200-day moving average price is $12.96.
Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.02). The firm had revenue of $95.35 million during the quarter, compared to analyst estimates of $94.80 million. On average, analysts expect that Core Scientific, Inc. will post 0.5 EPS for the current year.
Insider Buying and Selling at Core Scientific
In other Core Scientific news, insider Todd M. Duchene sold 25,000 shares of Core Scientific stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total value of $427,500.00. Following the sale, the insider now owns 1,661,474 shares of the company's stock, valued at $28,411,205.40. This trade represents a 1.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Yadin Rozov sold 105,000 shares of the company's stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $18.11, for a total value of $1,901,550.00. Following the transaction, the director now directly owns 345,239 shares of the company's stock, valued at $6,252,278.29. This represents a 23.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 349,043 shares of company stock valued at $5,449,345. 32.00% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on CORZ shares. Canaccord Genuity Group reaffirmed a "buy" rating and set a $17.00 price objective on shares of Core Scientific in a report on Thursday, November 7th. B. Riley raised their price target on Core Scientific from $16.00 to $17.00 and gave the company a "buy" rating in a report on Thursday, November 7th. Macquarie lifted their price objective on Core Scientific from $16.00 to $19.00 and gave the stock an "outperform" rating in a research report on Thursday, November 14th. Jefferies Financial Group started coverage on shares of Core Scientific in a research report on Monday, October 28th. They set a "buy" rating and a $19.00 target price on the stock. Finally, BTIG Research lifted their price target on shares of Core Scientific from $19.00 to $20.00 and gave the stock a "buy" rating in a research report on Monday, December 16th. Fourteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $18.86.
Get Our Latest Research Report on Core Scientific
Core Scientific Company Profile
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
See Also
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
